Elevated Urine Levels of Macrophage Migration Inhibitory Factor in Inflammatory Bladder Conditions: A Potential Biomarker for a Subgroup of Interstitial Cystitis/Bladder Pain Syndrome Patients

Urology - Tập 116 - Trang 55-62 - 2018
Pedro L. Vera1,2,3, David M. Preston1,4, Robert M. Moldwin5, Deborah R. Erickson4, Behzad Mowlazadeh6, Fei Ma1,2, Dimitrios E. Kouzoukas1,7, Katherine L. Meyer-Siegler8,6, Magnus Fall9
1Lexington VA Medical Center, Lexington, KY
2Department of Physiology, University of Kentucky, Lexington, KY
3Department of Surgery, University of Kentucky, Lexington, KY
4Department of Urology, University of Kentucky, Lexington, KY
5The Arthur Smith Institute for Urology, Zucker School of Medicine at Hofstra-Northwell, Lake Success, NY
6The Bay Pines VA Healthcare System, Bay Pines, FL
7Saha Cardiovascular Research Center, University of Kentucky, Lexington, KY
8Department of Natural Sciences, St. Petersburg College, St Petersburg, FL
9Department of Urology, Institute of Clinical Sciences, University of Gothenburg, Sahlgrenska University Hospital, Göteborg, Sweden

Tài liệu tham khảo

Berry, 2011, Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States, J Urol, 186, 540, 10.1016/j.juro.2011.03.132 Suskind, 2013, The prevalence and overlap of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome in men: results of the RAND Interstitial Cystitis Epidemiology male study, J Urol, 189, 141, 10.1016/j.juro.2012.08.088 Hanno, 2015, Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment, J Urol, 193, 1545, 10.1016/j.juro.2015.01.086 David, 1966, Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction, Proc Natl Acad Sci USA, 56, 72, 10.1073/pnas.56.1.72 Grieb, 2010, Macrophage migration inhibitory factor (MIF): a promising biomarker, Drug News Perspect, 23, 257, 10.1358/dnp.2010.23.4.1453629 Meyer-Siegler, 2004, Inhibition of macrophage migration inhibitory factor decreases proliferation and cytokine expression in bladder cancer cells, BMC Cancer, 4, 34, 10.1186/1471-2407-4-34 Meyer-Siegler, 2004, Substance P induced release of macrophage migration inhibitory factor from rat bladder epithelium, J Urol, 171, 1698, 10.1097/01.ju.0000115883.49365.1a Vera, 2010, Antagonism of macrophage migration inhibitory factor decreases cyclophosphamide cystitis in mice, Neurourol Urodyn, 29, 1451, 10.1002/nau.20878 Kouzoukas, 2016, Protease-activated receptor 4 induces bladder pain through high mobility group box-1, PLoS ONE, 11, 10.1371/journal.pone.0152055 Kouzoukas, 2015, Macrophage migration inhibitory factor mediates par-induced bladder pain, PLoS ONE, 10, 10.1371/journal.pone.0127628 Vera, 2009, Intraluminal blockade of cell-surface CD74 and glucose regulated protein 78 prevents substance P-induced bladder inflammatory changes in the rat, PLoS ONE, 4, 10.1371/journal.pone.0005835 Meyer-Siegler, 2006, Macrophage migration inhibitory factor is increased in the urine of patients with urinary tract infection: macrophage migration inhibitory factor-protein complexes in human urine, J Urol, 175, 1523, 10.1016/S0022-5347(05)00650-6 Cohen, 1988 R Core Team, 2017 Robin, 2011, pROC: an open-source package for R and S+ to analyze and compare ROC curves, BMC Bioinformatics, 12, 77, 10.1186/1471-2105-12-77 Blalock, 2012, Gene expression analysis of urine sediment: evaluation for potential noninvasive markers of interstitial cystitis/bladder pain syndrome, J Urol, 187, 725, 10.1016/j.juro.2011.09.142 Peeker, 2002, Toward a precise definition of interstitial cystitis: further evidence of differences in classic and nonulcer disease, J Urol, 167, 2470, 10.1016/S0022-5347(05)65006-9 Hillelsohn, 2012, Fulguration for Hunner ulcers: long-term clinical outcomes, J Urol, 188, 2238, 10.1016/j.juro.2012.08.013 Peeker, 2000, Complete transurethral resection of ulcers in classic interstitial cystitis, Int Urogynecol J Pelvic Floor Dysfunct, 11, 290, 10.1007/s001920070019 Cox, 2016, CUA guideline: diagnosis and treatment of interstitial cystitis/bladder pain syndrome, Can Urol Assoc J, 10, E136, 10.5489/cuaj.3786 Logadottir, 2012, Clinical characteristics differ considerably between phenotypes of bladder pain syndrome/interstitial cystitis, Scand J Urol Nephrol, 46, 365, 10.3109/00365599.2012.689008 Logadottir, 2004, Intravesical nitric oxide production discriminates between classic and nonulcer interstitial cystitis, J Urol, 171, 1148, 10.1097/01.ju.0000110501.96416.40 Parker, 2016, Urinary metabolomics identifies a molecular correlate of interstitial cystitis/bladder pain syndrome in a Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) research network cohort, EBioMedicine, 7, 167, 10.1016/j.ebiom.2016.03.040 Doiron, 2016, Clinical phenotyping does not differentiate Hunner lesion subtype of interstitial cystitis/bladder pain syndrome: a relook at the role of cystoscopy, J Urol, 196, 1136, 10.1016/j.juro.2016.04.067 Tyagi, 2012, Urinary chemokines as noninvasive predictors of ulcerative interstitial cystitis, J Urol, 187, 2243, 10.1016/j.juro.2012.01.034 Leng, 2003, MIF signal transduction initiated by binding to CD74, J Exp Med, 197, 1467, 10.1084/jem.20030286 Grigoryan, 2014, Diagnosis and management of urinary tract infections in the outpatient setting: a review, JAMA, 312, 1677, 10.1001/jama.2014.12842 Browne, 2015, A narrative review on the pathophysiology and management for radiation cystitis, Adv Urol, 2015, 10.1155/2015/346812 Hong, 2012, Urinary macrophage migration inhibitory factor serves as a potential biomarker for acute kidney injury in patients with acute pyelonephritis, Mediators Inflamm, 2012, 10.1155/2012/381358 Matsumoto, 2002, Urinary levels of macrophage migration inhibitory factor in patients with IgA nephropathy, Nephron, 92, 309, 10.1159/000063297